Furthermore, the low expression of Survivin is considered to be one of the factors for the success of chemotherapy; Bmi-1 promotes the drug resistance of B-cell lymphoma cells through the regulation of Survivin [171]. Here, BIRC5 is linked to B-cell non-Hodgkin lymphoma.